Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells
Scott M. Dehm(University of Minnesota), Donald J. Tindall(Mayo Clinic)
Cited by 113
Related Papers
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
|Nucleic Acids Research|2015|151
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer
|Cancer Immunology Research|2024|9